NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Gestalt Diagnostics

Gestalt Diagnostics

Private
Spokane, WashingtonHealthcare & Life Scienceshttps://gestaltdiagnostics.com/

Last Round

Series A

Apr 28, 2025

Total Funding Raised

$13.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Gestalt Diagnostics is a healthcare technology company that provides an AI-powered, cloud-based digital pathology platform to help pathologists diagnose diseases faster and more efficiently.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital pathologypathology workflowlaboratory information systemsLISmedical imagingpathology softwaredigital slide managementAI-enabled pathologypathology AIcloud-based pathologyvendor-neutral platformenterprise healthcare softwareremote pathologytelepathologyworkflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gestalt Diagnostics Comps

Public and private peers based on sector, stage, and business model.

Gestalt Diagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gestalt Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 28, 2025
SeedMar 1, 2021
View all Funding Rounds

Gestalt Diagnostics Investors

Notable investors and investment history

Gestalt Diagnostics investors
InvestorRounds
Cowles VenturesSeed, Series A
Tacoma Venture FundSeed, Series A
KickstartSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Grew 15% QoQ, from 33 to 38 employees.

  • Apr 1, 2026

    Added Aicpalearning as a customer

View all signals

Gestalt Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gestalt Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gestalt Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSpokane, Washington
Employee Range39
Year Founded2017
Last FundingApr 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.